Chi-Med has announced the sale of 12m ADS at a price of $24.00/ADS in an upsized secondary placing by Hutchison Healthcare Holdings Ltd (HHHL), its largest shareholder and a subsidiary of CK Hutchison Holdings. A further 1.8m ADS have been offered to the underwriter under a 30-day option.
28 Jun 2019
Hutchison China MediTech (Chi-Med)
Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
Hutchison China MediTech (Chi-Med)
HUTCHMED (China) Limited (HCM:LON) | 267 -2.7 (-0.4%) | Mkt Cap: 2,326m
- Published:
28 Jun 2019 -
Author:
Franc Gregori -
Pages:
3
Chi-Med has announced the sale of 12m ADS at a price of $24.00/ADS in an upsized secondary placing by Hutchison Healthcare Holdings Ltd (HHHL), its largest shareholder and a subsidiary of CK Hutchison Holdings. A further 1.8m ADS have been offered to the underwriter under a 30-day option.